WisdomTree Launches India Smart Beta Physical UCITS ETF
New Indian equities fund provides a focus on companies with quality earnings
WisdomTree, the exchange traded fund (“ETF”) and exchange traded product (“ETP”) sponsor, today announced the launch of accumulating and distributing share classes of the WisdomTree India Quality UCITS ETF (EPIQ) on the London Stock Exchange, offering smart beta exposure to Indian stocks with a focus on quality as measured by above average returns on assets (ROA) and return on equity (ROE).
The Indian equity market offers an exciting opportunity for investors; it represents the world’s seventh largest economy and the fourth largest equity market within emerging markets.
In addition, having recently grown at a rate of 7.5% per annum, the IMF estimates that India will be the world’s fastest growing large economy over the next five years and they expect growth to average 8.1%. WisdomTree believes these positive fundamentals are underpinned by favourable demographics, a boost to fiscal spending, a lowering of tax rates and a stable political climate committed to reform.
The new UCITS ETF tracks the WisdomTree India Quality Index, focused on the top 33% of companies using a combined ranking of the three-year average return on assets and return on equity. The index constituents are then weighted by market capitalisation. These factors have provided consistent exposure to quality stocks, offering the potential to deliver above average risk adjusted returns.
“We’re excited to be launching EPIQ, an innovative ETF that provides a quality tilt on the Indian equity market,” said Nizam Hamid, ETF Strategist. “Our Fund has the advantage of diversification, with over 100 constituents, and a broad sector exposure tilted towards the core drivers of growth in the Indian economy.”
“With a favourable global macro environment, decisive policy making and exciting growth trends, India has a compelling strategic as well as tactical allocation investment case,” Hamid added.
Morgan Lee, Head of European Distribution, said, “Investors have expressed enthusiastic interest in gaining exposure to the Indian equity market via a physically replicating UCITS ETF as, up until now, investor choices have been limited. The addition of our quality titled methodology provides a differentiated solution for those looking to allocate towards this exciting market.”
The Fund lists on the London Stock Exchange following on from its listing on the Borsa Italiana and the Deutsche Börse last week.
|Fund||Income Treatment||Ticker||ISIN||Listing Currency||Base Currency|
|WisdomTree India Quality UCITS ETF – USD||Distributing||EPIQ||IE00BDGSNK96||GBP||USD|
|WisdomTree India Quality UCITS ETF – USD Acc||Accumulating||EPIE||IE00BDGSNL04||USD||USD|
– Ends –
Notes to editors
WisdomTree Investments, Inc., through its subsidiaries in the US, Europe and Japan (collectively, “WisdomTree”), is an exchange traded fund (“ETF”) and exchange traded product (“ETP”) sponsor and asset manager. WisdomTree offers products covering equities, fixed income, currencies, commodities and alternative strategies. Through WisdomTree Europe Ltd, it sponsors WisdomTree UCITS ETFs and Boost short and leverage ETPs. WisdomTree currently has approximately $41.7 billion (as of 31 January 2017) in assets under management globally. For more information, please visit www.wisdomtree.com.
WisdomTree® is the marketing name for WisdomTree Investments, Inc. and its subsidiaries worldwide.
This document is issued by WisdomTree Europe Ltd (“WTE”), an appointed representative of Mirabella Advisers LLP, which is authorised and regulated by the Financial Conduct Authority (“FCA”) in the United Kingdom. View our Conflicts of Interest Policy and Inventory at www.wisdomtree.eu/cofi. The UCITS products discussed in this document are issued by WisdomTree Issuer PLC (the “Issuer”), an umbrella investment company with variable capital having segregated liability between its funds and organised under the laws of Ireland as a public limited company. The Issuer has been authorised by the Central Bank of Ireland (“CBI”) and is organised as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the laws of Ireland and shall issue a separate class of shares (“Shares”) representing each fund. Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus entitled “Risk Factors” for further details of risks associated with an investment in the Shares. Any decision to invest should be based on the information contained in the Prospectus and after seeking independent investment, tax and legal advice. The Share may not be available in your market or suitable for you. This document does not constitute investment advice nor an offer for sale nor a solicitation of an offer to buy Shares. This document should not be used as the basis for any investment decision.
The price of any Shares may go up or down and an investor may not get back the amount invested. Past performance is not a reliable indicator of future performance. Any historical performance included in this document may be based on back testing. Back testing is the process of evaluating an investment strategy by applying it to historical data to simulate what the performance of such strategy would have been. However, back tested performance is purely hypothetical and is provided in this document solely for informational purposes. Back tested data does not represent actual performance and should not be interpreted as an indication of actual or future performance. The value of the Shares may be affected by exchange rate movements.
This document may contain independent market commentary prepared by WisdomTree Europe based on publicly available information. WisdomTree Europe does not warrant, guarantee or otherwise confirm the accuracy or correctness of any information contained herein and any opinions related to product or market activity may change.
This document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of Shares in the United States or any province or territory thereof, where none of the Issuer or the Shares are authorised or registered for distribution and where no Prospectus of the Issuer has been filed with any securities commission or regulatory authority. Neither this document nor any copy hereof should be taken, transmitted or distributed (directly or indirectly) into the United States. Neither the Issuer nor any securities issued by it have been or will be registered under the United States Securities Act of 1933 or the Investment Company Act of 1940 or qualified under any applicable state securities statutes.